Evaluation of HRM for the detection of third-generation cephalosporin and azithromycin resistance genes in Neisseria gonorrhoeae

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048771

Enrollment

Unknown

Registered

2021-07-16

Start date

2021-07-16

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonorrhea and Neisseria gonorrhoeae strains(NG)

Interventions

Gold Standard:MIC data, gene sequencing for Neisseria gonorrhoeae

Index test:Conformity&#32

rate&#32

(positive,&#32

negative),&#32

consistenc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Basis for sample selection: Swabs: genitourinary swabs from patients suspected of gonorrhea infection. Strain: pure gonococcus strain; 2. Inclusion criteria: (1) The collection and processing of samples meet the requirements of standard laboratory operations and product instructions; (2) The sample information is complete; (3) The sample size meets the needs of clinical trials; (4) The patient must be a person over the age of 18 with the ability to act.

Exclusion criteria

Exclusion criteria: Repeated samples from the same patient.

Design outcomes

Primary

Measure	Time frame
MIC data of NG;drug resistance gene for NG;	—

Countries

China

Contacts

Public ContactGu Weiming

Shanghai Skin Disease Hospital

weiming_gu2003@aliyun.com+86 18017336651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026